However, no significant differences were observed in the mRNA expression levels of CD155 in CD33+ cells between patients with MDS and HDs, whilst a significant difference was observed in CD34+ cells (Figure 4C). This evidence concerns the gene CD34 and myelodysplastic syndrome.